ABVC BIOPHARMA, INC.
ABVC BIOPHARMA, INC. (ABVC): 9 pipeline candidates · ~1 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
1.1 months
D/E 0.64 · 0% dilution
Lead: Phase 2
9 candidates
N/A
N/A
A transparent, data-derived signal for ABVC BIOPHARMA, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$32.8M
Cash
$140K
Quarterly Burn
$894K
Runway
1.1 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (9 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
13
Total value held
$977K
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 381,148 | $370K |
| geode capital management, llc | 221,169 | $215K |
| vanguard fiduciary trust co | 97,363 | $94K |
| renaissance technologies llc | 95,100 | $92K |
| state street corp | 72,800 | $71K |
| blackrock, inc. | 56,442 | $55K |
| northern trust corp | 32,087 | $31K |
| two sigma securities, llc | 21,023 | $20K |
| dimensional fund advisors lp | 12,227 | $12K |
| jane street group, llc | 10,700 | $10K |
Showing top 10 of 13 institutional holders of ABVC BIOPHARMA, INC.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in ABVC BIOPHARMA, INC.'s pipeline?
ABVC BIOPHARMA, INC. (ABVC) has 9 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is ABVC BIOPHARMA, INC.'s lead drug candidate?
ABVC BIOPHARMA, INC.'s most advanced tracked candidate is abv-1501 (Phase 2) for Triple Negative Breast Cancer (TNBC).
What is ABVC BIOPHARMA, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, ABVC BIOPHARMA, INC. has approximately 1.1 months of cash runway.
What is ABVC BIOPHARMA, INC.'s market capitalization?
ABVC BIOPHARMA, INC.'s market capitalization is approximately $32.8M.
Who is the CEO of ABVC BIOPHARMA, INC.?
Dr. Uttam Yashwant Patil Ph.D. is the chief executive officer of ABVC BIOPHARMA, INC. (ABVC).
Get the full picture on ABVC BIOPHARMA, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.